Dr Koshiyama is the author of Diabetes Mellitus as Dysfunction of Interactions Among all Organs: “Ominous Orchestra of Organs” which was recently published in Clinical Medicine: Endocrinology and Diabetes.

The Editor in Chief of Clinical Medicine: Endocrinology and Diabetes recently issued a call for papers.

Dr Koshiyama is a member of our favorite authors program. Under the program authors are eligible to receive: prioritised peer review, prioritised author PDF, and an article processing fee discount. All former authors are eligible to join the favorite author program.

Please describe your experience with Libertas Academica

My experience with Libertas Academica was excellent. The review process was smooth and speedy. After publishing, I received a kind and favorable response from a reader. I have never experienced such a comment after my publications to orthodox journals.

What is the primary focus of your research?

My primary focus is clinical endocrinology and diabetes mellitus, especially in relation to its macrovascular complications.

What are the most exciting developments arising from current research in your area?

I think that the effectiveness of incretin analog and/or enhancer in Japanese type 2 diabetes is one of the exciting topics.

Who are your main collaborators?

Emeritus Professor Yutaka Seino.

How did you come to be working in your research area?

After I entered Professor Imura's Lab at the Postgraduate School of Medicine, Kyoto University.

What do you think about the development of open access publishing? What motivated you to use it?

I think that it will enable us to collaborate with other researchers. In this era, I think that the sharing of data and concepts should be more open.

What articles and/or books have you published recently?

• Koshiyama H, Taniguchi A, Tanaka K, Kagimoto S, Fujioka Y, Hirata K, Nakamura Y, Iwakura A, Hara K, Yamamoto T, Kuroe A, Ohya M, FujimotoS, Hamamoto Y, Honjo S, Ikeda H, Nabe K, TsudaK, Inagaki N, Seino Y, Kume N. Effects of pitavastatin on lipid profiles and high-sensitivity CRP in Japanese subjects with hypercholesterolemia :Kansai Investigation of Statin for Hyperlipidemic Intervention in Metabolism and Endocrinology (KISHIMEN) Investigators. Journal of Atherosclerosis and Thrombosis 2008; 15(6): 345-350

• Ikeda H, Nakamura Y, Minamikawa J, Honjo S, Hamamoto Y, Wada Y, Nabe K, Koshiyama H. Comparison of Effects of Amlodipine and Angiotensin Receptor Blockers on the Intima-media Thickness of Carotid Arterial Wall (AAA Study: Amlodipine vs ARB in Atherosclerosis Study) Diabetes Res Clin Pract 2009; 83:117-50-53

• Ikeda H, Honjo S, Hamamoto Y, Wada Y, Nabe K, Koshiyama H. Olmesartan reduced microalbuminuria in Japanese subjects with type 2 diabetes. Diabetes Res Clin Pract 2009; 83: 117-118.

• Kimura T, Ikeda H, Fujikawa J, Nomura K, Aoyama T, Nabe K, Hamamoto Y, Honjo S, Koshiyama H. Usefulness of serum cystatin C as a marker of diabetic nephropathy in Japanese subjects with type 2 diabetes. Diabetes Res Clin Pract 2009 83(2):e58-61.

• Koshiyama H, Ogawa Y, Tanaka K, Tanaka I. Integrated Network Systems and Evolutionary Developmental Endocrinology. Medical Hypotheses 2009.

• Honjo S, Ikeda H, Kawasaki Y, Wada Y, Hamamoto Y, Aoyama T, Kimura T, Nomura K, Koshiyama H. Efficacy and safety of miglitol:switching study from voglibose in Japanese patients with type 2 diabetes. The Open Diabetes Journal 2009;2:60-61

• Nishi Y, Koshiyama H, Honjo S, Seino Y. Poor Correlation of pulse wave velocity and intima-media thickness in diabetic subjects (letter). Diabetes Care 2004;

• 27(8):2084.Koshiyama H, Ikeda H, Honjo S, Nakamura Y, Tanaka K, Tsugawa N, Okano T. Hypovitaminosis D is frequent in Japanese subjects with type 2 diabetes (letter). Diabetes Res Clin Pract 2007;76:470-1Koshiyama H, Inagaki N, Seino Y. Which we should ADOPT: sulfonylureas or glitazones?(letter) Diabetic Medicine 2007; 24(7):804

More information

Center for Diabetes and Endocrinology

share on